Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Hester Biosciences Limited
HESTERBIO | NSE
1,365.60
INR106.50
8.46%
HESTERBIO | NSE
Loading StockChartView...
About Hester Biosciences Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
1,365.60
Open
1,275.00
High
1,379.90
Low
1,275.00
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases such as newcastle disease infectious bronchitis infectious bursal disease fowl pox egg drop syndrome reo marek's disease infectious coryza fowl cholera mycoplasma gallisepticum inclusion body hepatitis avian encephalomyelitis etc. It also offers vaccines for large animals comprising Goat Pox Peste des Petits Ruminants Brucellosis Mastitis Metritis and various infectious diseases as well as infections reproductive disorders theileriosis parasitic diseases etc. In addition the company provides feed supplements such as toxin binder trace minerals enzyme preparation and bypass fat; disinfectants for farms and equipment and water sanitizers; nutrition products consisting of mineral mixtures fertility supplements and growth tonics; and herbal products including growth promoters herbal replacers for choline chloride stress relievers and immunity boosters respiratory stimulants liver tonics wound healing preparations uterine tonics digestive tonics and anti-bloat solutions ectoparasiticide preparations anti-mastitis and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad India.
View LessHESTERBIO | NSE
Risk
45.6
Sharpe
-0.16
Luna's Score
43/100
Recommendation
Sell
Luna says (HESTERBIO | NSE)
What's Working
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
64.5%1 month
45.6%3 months
34.4%6 months
27.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
104.15
Fwd. PE
-
Price to book
6.81
Debt to equity
0.84
Debt to assets
0.37
Ent. to EBITDA
36.22
Ent. to rev.
7.40
PEG
-
Other Fundamentals
EBITDA
637.49M
MarketCap
11.62B
MarketCap(USD)
124.43M
Div. yield
0.25
Op. margin
17.66
Erngs. growth
11.50
Rev. growth
-6.20
Ret. on equity
7.16
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
210.70
Range1M
320.70
Range3M
404.70
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.59
Price X volume
4.69M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 36.22 | 24.85 | Expensive |
| Ent. to Revenue | 7.40 | 11.40 | Cheaper |
| PE Ratio | 104.15 | 51.36 | Expensive |
| Price to Book | 6.81 | 6.83 | Par |
| Dividend Yield | 0.25 | 0.52 | Poor |
| Std. Deviation (3M) | 34.39 | 42.17 | Par |
| Debt to Equity | 0.84 | 0.35 | Expensive |
| Debt to Assets | 0.37 | 0.17 | Expensive |
| Market Cap | 11.62B | 290.82B | Emerging |
